EVAX ▲ +1.9% - Evaxion A/S
$EVAX - Evaxion applies its AI-Immunology™ platform in autoimmune diseases
Evaxion shares rose 1.9% following the company's announcement that it is applying its AI-Immunology platform to autoimmune disease research, expanding the potential application scope of its proprietary technology beyond its current focus areas.
14-SEP-2026 08:00 AM ET
Share this post
💬 Comments
Loading comments…
Leave a comment
